Iradimed

Iradimed

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$20,466
$21,979
$22,692
$21,202
Gross Profit
15,160
16,814
17,032
16,494
EBITDA
6,800
8,224
8,405
7,681
EBIT
6,391
7,769
7,791
7,297
Net Income
5,218
5,818
6,442
5,576
Net Change In Cash
20,466
21,979
22,692
21,202
Free Cash Flow
5,755
7,887
5,440
5,848
Cash
59,080
56,374
51,159
56,526
Basic Shares
12,872
12,870
12,875
12,860

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$83,814
$73,242
$65,562
$53,303
Gross Profit
64,324
56,349
50,158
41,282
EBITDA
30,741
25,093
20,035
16,298
EBIT
28,361
24,275
20,035
15,627
Net Income
22,480
19,234
17,192
12,827
Net Change In Cash
83,814
73,242
65,562
53,303
Cost of Revenue
-4,038
Free Cash Flow
17,182
17,619
5,457
8,167
Cash
51,159
52,233
49,762
57,960
Basic Shares
12,854
12,783
12,722
12,635

Earnings Calls

QuarterEPS
2026-06-30
$0.41
2026-03-31
$0.49
2025-12-31
$0.54
2025-09-30
$0.47